{
  "title": "The COVID-19 Vaccine Trial Results: What They Mean, What Comes Next",
  "description": "Interim <a href=\"https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against\">results are in</a> from a large trial of an experimental COVID-19 vaccine. Drug maker Pfizer, working with German company BioNTech, says its vaccine appears to be working really well  — it was found to be more than 90 percent effective.  Today on Short Wave, host Maddie Sofia talks to NPR science correspondent Joe Palca about what that efficacy number means, details of the study and what more information about the vaccine researchers are awaiting.<br/><br/>Reach the show by emailing us at <a href=\"mailto:shortwave@npr.org\">shortwave@npr.org</a>. ",
  "pubDate": "Fri, 13 Nov 2020 04:00:12 -0500",
  "copyright": "Copyright 2019-2021 NPR - For Personal Use Only",
  "guid": "63ce4c84-b635-4601-989b-e6f802cd0f35",
  "link": "https://www.npr.org/2020/11/12/934164473/the-covid-19-vaccine-trial-results-what-they-mean-what-comes-next",
  "itunes:title": "The COVID-19 Vaccine Trial Results: What They Mean, What Comes Next",
  "itunes:author": "NPR",
  "itunes:summary": "A COVID-19 vaccine candidate seems to be working really well, interim results show.  How well is the vaccine working and what are the next steps in this vaccine's development?",
  "itunes:subtitle": "A COVID-19 vaccine candidate seems to be working really well, interim results show.  How well is the vaccine working and what are the next steps in this vaccine's development?",
  "itunes:image": "",
  "itunes:duration": 639,
  "itunes:explicit": "no",
  "itunes:episodeType": "full",
  "content:encoded": "Interim <a href=\"https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against\">results are in</a> from a large trial of an experimental COVID-19 vaccine. Drug maker Pfizer, working with German company BioNTech, says its vaccine appears to be working really well  — it was found to be more than 90 percent effective.  Today on Short Wave, host Maddie Sofia talks to NPR science correspondent Joe Palca about what that efficacy number means, details of the study and what more information about the vaccine researchers are awaiting.<br/><br/>Reach the show by emailing us at <a href=\"mailto:shortwave@npr.org\">shortwave@npr.org</a>. ",
  "enclosure": ""
}